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Compartmentalization of Bacterial Antigens:
Differential Effects on Priming of CD8 T Cells
and Protective Immunity
cells. Variables that determine which bacterial antigens
elicit CD8 T cell responses and which of these target
antigens contribute to protective immunity are largely
undefined.
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a gram-positive facultative intracellular bacterium, re-Emory University School of Medicine
sults in the generation of MHC class I restricted CD8Atlanta, Georgia 30322
T cells that can transfer protective immunity to naive²Department of Microbiology and Immunology
animals (reviewed by Kaufmann, 1993). Recent ad-UCLA School of Medicine
vances in elucidating the intracellular life cycle of LMMolecular Biology Institute
(Cossart and Mengaud, 1989; Tilney and Portnoy, 1989;University of California, Los Angeles
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nity. LM can enter, survive, and multiply within bothUniversity of Iowa
phagocytic and nonphagocytic cells. Immediately fol-Iowa City, Iowa 52242
lowing entry, LM disrupts the membrane-bound vacuole
by a mechanism mediated primarily by a hemolysin,
listeriolysin O (LLO; Bielecki et al., 1990), and assistedSummary
by two phospholipases (Smith et al., 1995). Once in the
cytoplasm of an infected cell, LM multiplies rapidly andBacterial pathogens synthesize numerous proteins
utilizes actin-based motility to spread directly intothat are either secreted or localized within bacterial
neighboring cells (Kocks et al., 1992; Smith et al., 1996).cells. To address the impact of antigen compartmen-
Whereas escape from the vacuole allows LM to avoidtalization on T cell immunity, we constructed recombi-
bactericidal effects of phagolysosomal fusion, entry intonant Listeria monocytogenes that express a model
the host cell cytoplasm exposes bacterial antigens toCD8 T cell epitopeas a secreted or nonsecreted fusion
the endogenous MHC class I pathway for processingprotein. Both forms of the antigen, either secreted into
and presentation to CD8 T cells (Brunt et al., 1990).the host cell cytoplasm or retained within bacterial
The endogenous pathway of MHC class I antigen pre-cells, efficiently prime CD8 T cell responses. However,
sentation initiates with cytosolic proteins, either self- orepitope-specific CD8 T cells confer protection only
pathogen-derived, which are degraded by the proteo-against bacteria secreting the antigen but not against
some (reviewed by York and Rock, 1996). The resultingthe bacteria expressing the nonsecreted form of the
peptides are actively pumped into the endoplasmic re-same antigen. This dichotomy as a result of antigen
ticulum where they bind to nascent MHC class I mole-compartmentalization suggests that bacterial anti-
cules and are transported to the cell surface for recogni-gens are presented by multiple MHC class I pathways
tion by CD8 T cells. This process displays on the cellto prime CD8 T cells, but only the endogenouspathway
surface a ªsampling,º in peptide form, of intracellularprovides target antigens for CD8 T cell±mediated pro-
proteins for surveillance by CD8 T cells. However, anti-
tective immunity.
gens without obvious access to the cytoplasm may also
be presented by MHC class I molecules in vivo, a phe-
Introduction nomenon originally described as cross-priming (Bevan,
1976). Recent studies have demonstrated that profes-
CD8 T lymphocytes recognize infected cells which dis-
sional antigen-presenting cells (APC) such as macro-
play pathogen-derived peptides bound to cell surface
phages are responsible for processing and presenting
major histocompatibility complex (MHC) class I mole- exogenous antigens to CD8 T cells (reviewed by Jondal
cules (York and Rock, 1996). Upon recognition, CD8 T et al., 1996). In vitro experiments suggest at least two
cells express a variety of effector functions, including routes for presentation of exogenous antigens: a cytosol
killing of infected target cells and secretion of inter- dependent pathway involving translocation of the exog-
feron-g (IFNg). CD8 cytotoxic T lymphocytes (CTL) play enous antigen from the phagosome to the cytoplasm
a major role in protective immunity against viruses as (Kovacsovics and Rock, 1995), and a cytosol indepen-
well as intracellular bacteria (Kaufmann, 1993; Ahmed dent pathway involving peptide loading of MHC class I
and Gray, 1996). Unlike viruses with limited genome size, molecules targeted to vacuoles containing degraded
bacteria have the coding capacity to produce thousands antigen (Jondal et al., 1996) or regurgitation of the re-
of distinct proteins that are sorted into different bacterial sulting peptides to bind surface MHC class I molecules
compartments. Bacterial pathogens thus provide a com- (Pfeifer et al., 1993). It is assumed that one or both
plex array of potential targets for recognition by CD8 T of these pathways account for priming of CD8 T cell
responses to exogenous antigens in vivo. The efficiency
of exogenous MHC class I antigen presentation path-§To whom correspondence should be addressed.
ways and theircontribution to immunity against infection| Present address: Department of Microbiology, University of Penn-
sylvania School of Medicine, Philadelphia, Pennsylvania 19104. are currently unknown.
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Proteins secreted by intracellular LM into the host cell
cytosol are readily accessible to the endogenous MHC
class I antigen processing pathway. Three CD8 T cell
epitopes have been identified from secreted proteins of
LM (Pamer et al., 1991; Vijh and Pamer, 1997), and CTL
specific to two of these epitopes provide significant
immunity to LM infection (Harty and Bevan, 1992; Harty
and Pamer, 1995). In contrast, no CD8 T cell epitopes
from nonsecreted LM proteins have been described.
However, a study (Schafer et al., 1992) has demon-
strated the induction of CD8 T cells against b-galactosi-
dase, which was expressed but not specifically targeted
for secretion in LM. During LM infection, many bacteria
are killed in the phagosome of activated macrophages
(North, 1970; Portnoy et al., 1989; de Chastellier and
Berche, 1994). After bacterial lysis, nonsecreted proteins
become available for presentation by the exogenous
MHC class I pathways that originate in the phagosome.
In this study, we have examined the effect of bacterial
antigen compartmentalization on in vivo priming of CD8
T cells and protective immunity against bacterial infec-
tion. Our results show that recombinant LM (rLM) strains
expressing either a secreted or nonsecreted form of a
model CD8 T cell epitope can efficiently induce epitope-
specific CD8 T cell responses. However, epitope-spe-
cific memory CD8 T cells confer protection only against
rLM secreting the epitope but not against rLM express-
ing the nonsecreted epitope. Thus, bacterial antigen
compartmentalization has differential impact on in vivo
Figure 1. Isogenic Strains of Recombinant LM Expressing the LCMVCD8 T cell priming and protective antibacterial im-
NP 118-126 Epitope in a Secreted or Nonsecreted Fusion Proteinmunity.
(A) Diagram of antigen cassettes integrated into the bacterial ge-
nomeat a specific site between two convergent transcriptional units,
lecithinase operon and lactate dehydrogenase (LDH) operon, and
Results downstream from a putative transcriptional terminator. HSL235 and
HSL236 express a Hly9-PhoA fusion without or with the LCMV NP
Isogenic Strains of rLM Expressing a Model 118-126 epitope and serve as a negative and positive control, re-
spectively. XFL303 and XFL304 are a pair of isogenic strains thatCD8 T Cell Epitope in a Secreted
express a fusion protein consisting of the NP 118-126 epitope±fusedor Nonsecreted Fusion Protein
to DHFR, monoclonal antibody epitopes (ha and vg), and sequencesQuantitative analysis of the impact of antigen compart-
containing the hly promoter (Phly), the translation start codon (M)
mentalization on immunogenicity requires a direct com- with the signal sequence (SS) in XFL303 and without the signal
parison of the same antigen that isexpressed in different sequence in XFL304. The signal sequence in XFL303 contains five
bacterial compartments. We have previously described Hly residues downstream from the cleavage site to ensure efficient
cleavage and secretion. All antigen cassettes carry a kanamycina geneticsystem for expression and secretion of heterol-
resistance marker (Aph-A3).ogous antigens by rLM, based on stable site-specific
(B) Western blot analysis of expression and localization of fusionintegration of ªantigen cassettesº into the bacterial ge-
proteins. The fusion proteins in the total protein preparations (Total)
nome (Shen et al., 1995). In this study, we constructed and in the secreted protein fractions (Secreted) were detected using
a pair of isogenic strains of rLM that express, within a antibodies specific to PhoA (HSL235 and HSL236) and to ha and
secreted or nonsecreted dihydrofolate reductase (DHFR) vg (XFL303 and XFL304). 10403S is the parental wild-type strain
from which all of the rLM strains are derived. The slight mobilityfusion protein, a H-2Ld-restricted epitope (NP 118-126)
shift of the fusion proteins between HSL235 and HSL236 reflects thefrom the nucleoprotein of lymphocytic choriomeningitis
addition of NP 118-126 epitope sequence in HSL236, and betweenvirus (LCMV). Strain XFL303 contains an antigen expres-
XFL303 and XFL304 the five Hly residues at the N terminus of the
sion cassette consisting of NP 118-126 fused to DHFR, mature protein after signal sequence cleavage in XFL303.
the hly promoter, translation initiation and secretory sig-
nal sequences. XFL304 is identical to XFL303 except
the fusion protein is missing the N-terminal secretion Western blot analysis was used to analyze expression
and secretion of fusion proteins. As shown in Figure 1B,signal (Figure 1A). Two previously characterized strains,
HSL235 and HSL236, were used as a negative and posi- similar amounts of the fusion proteins were present in
the total protein preparations as well as in the secretedtive control. HSL236 expresses the LCMV NP 118-126
epitope within a secreted Hly9-PhoA fusion and has been fractions of HSL235 and HSL236, indicating that the
fusion proteins are synthesized and secreted efficientlyshown to induce NP 118-126 specific CD8 T cells (Shen
et al., 1995; Slifka et al., 1996). HSL235 expresses the by these strains. The DHFR fusion proteins were de-
tected in the total protein preparations of XFL303 andsame Hly9-PhoA fusion as HSL236 but without the NP
118-126 epitope. XFL304. In the case of XFL303, a similar amount was
Compartmentalization of Bacterial Antigens
537
or XFL304. The same dose response was observed for
CD8 T cell responses to two native LM epitopes, LLO
91-99 and p60 217-225 (Figure 2). The magnitude of the
responses increased with increasing doses, although it
was slightly less pronounced for p60 217-225 and the
nonsecreted NP 118-126 than for LLO 91-99 and the
secreted NP 118-126 epitopes. When the same immu-
nizing doses were compared, the responses to either
of the native LM epitopes were similar in mice immu-
nized with different strains, demonstrating equivalent
overall antigen load. Remarkably, the frequency of NP
118-126 specific CD8 T cells induced by the secreted
and nonsecreted epitope was also similar. At doses
of 1,000 and 5,000 bacteria, there were approximately
2- and 5-fold differences, respectively. Even at the low
dose of 300 bacteria, where only a subset of mice had
detectable epitope-specific CD8 T cells (1/6 in XFL303
and 2/6 in XFL304 immunized group), the magnitude
of the response was only 4-fold lower in the XFL304
immunized mice than in the XFL303 immunized mice.
Thus, the nonsecreted bacterial antigen can efficiently
prime a CD8 T cell response, even at the suboptimal
immunizing dose.
We next assessed the establishment of CD8 T cell
memory by measuring epitope-specific CD8 T cells at
day 60 after immunization with a dose of 1000 bacteriaFigure 2. Priming of CD8 T Cells
(0.1 LD50). In addition to IFNg Elispot assays, we usedMice were immunized with different doses of rLM expressing the
limiting dilution assays (LDA) to measure the frequencysecreted (XFL303) or nonsecreted (XFL304) NP 118-126 epitope and
of NP 118-126 specific cytotoxic T lymphocyte precur-the wild-type strain 10403S. CD8 T cells specific to NP 118-126,
LLO 91-99, andp60 217-225 werequantitated by IFNg Elispotassays sors (CTLp). As recently shown by Lalvani et al. (1997)
at day 7 after immunization. Each symbol represents an individual and Murali-Krishna et al. (1998), LDA underestimates
animal, and the dotted lines indicate the limit of detection (,2 3 the frequency of epitope-specific CD8 T cellsby approx-
103/spleen).
imately 10-fold compared to IFNg Elispot assays (Figure
3). Nevertheless, in both assays the relative difference
present in the secreted fraction compared to the total in the number of NP 118-126 specific memory CD8 T
protein preparation, indicating efficient secretion of the cells between XFL303 and XFL304 immunized mice was
fusion protein in this strain. In contrast, no DHFR fusion approximately 3-fold, similar to the ratios observed dur-
was detectable in the secreted fraction of XFL304 cul- ing the primary response at day 7. Taken together, these
tures. This was true even after prolonged exposure of results provide quantitative evidence that a nonsecreted
the blot (data not shown). These results demonstrate bacterial antigen, which is not readily accessible by the
that comparable amounts of the epitope containing endogenous MHC class I pathway, can prime CD8 T
DHFR fusion proteins are made by rLM strains XFL303 cell responses to levels similar to those primed by an
and XFL304 and that the DHFR fusion is efficiently se- efficiently secreted counterpart.
creted from XFL303 while it is exclusively localized
within the bacterial cells of XFL304.
Memory CD8 T Cells Induced by Nonsecreted
Bacterial Antigens Mount an EffectiveNonsecreted Bacterial Antigens Can Efficiently
Prime CD8 T Cells In Vivo In Vivo Anamnestic Response
In naive animals the virulent strain of LCMV, clone 13,The isogenic strains XFL303 and XFL304, which differ
only in the location of the model antigen, provide an establishes persistent infections characterized by low
CD8 T cell responses and high levels of infectious virusexperimental system to specifically address the impact
of antigen compartmentalization on priming of CD8 T (Ahmed et al., 1984). In contrast, immune mice mount
an accelerated CTL recall response that controls LCMVcells. Balb/c (H-2d) mice were immunized with a range
of sublethal doses of rLM, and priming of CD8 T cells clone 13 infection (Lau et al., 1994). An enhanced sec-
ondary response and protection against LCMV chal-was measured by IFNg Elispot assays at day 7 after
immunization (Figure 2). In mice immunized with approx- lenge thus provide in vivo markers for the presence of
LCMV epitope±specific memory CD8 T cells induced byimately 100 bacteria, epitope-specific CD8 T cells were
below the limit of detection. At a dose of around 300 previous immunization.
Two months after immunization with rLM strains, micebacteria, they were detected sporadically in both XFL303
(secreted NP 118-126) and XFL304 (nonsecreted NP were challenged with LCMV clone 13, and the immune
response was analyzed on day 8 post±LCMV infection.118-126) immunized mice. Increasing the dose to 1,000
or 5,000 bacteria resulted in priming of NP 118-126 spe- Expansion and activation of total CD8 T cells were mea-
sured by flow cytometry analysis after double stainingcific CD8 T cells in all mice immunized with either XFL303
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Figure 4. Enhanced Recall Response and Protective Immunity
against LCMV Challenge in Mice Immunized with rLMFigure 3. Establishment of CD8 T Cell Memory
Balb/c mice were immunized with the rLM strains and 2 monthsBalb/c mice (3/group) were immunized with the rLM strains as well
later were challenged with LCMV clone 13. Three mice from eachas LCMV Armstrong. Two months after immunization, the frequency
group were sacrificed on day 8 after LCMV challenge for analysisof NP 118-126 specific CTLp were determined by LDA (A), and the
of CD8 T cell responses, and three mice were bled on day 3, 8, 22,number of IFNg-secreting T lymphocytes (ISL) specific to LCMV NP
and 30 to monitor the virus titers in the serum. Data represent118-126 and two native LM epitopes, LLO 91-99 and p60 217-225,
means 6 standard deviations.were measured by IFNg Elispot assays (B). Data represent means 6
(A) Flow cytometry analysis of CD8 T cell expansion/activation.standard deviations.
Spleen cells were stained with antibodies specific to the CD8 mole-
cule and the T cell activation marker, LFA-1. Shown are the profiles
of one representative mouse from each group and, for comparison,
a naive mouse without LCMV challenge. Profiles of rLM immunizedsplenocytes for CD8 and LFA-1(CD11a), an adhesion
mice before LCMV challenge were very similar to that of the naivemolecule that is expressed at higher levels on the sur-
mouse (data not shown). Numbers in the upper quadrants indicate
face of activated T cells (de Vries et al., 1989). LCMV percentage of total spleen cells.
clone 13 infection in mice immunized with the epitope- (B) Number of IFNg-secreting T lymphocytes specific to NP 118-
negative control strain HSL235 induced a small increase 126 as determined by IFNg Elispot assays.
(C) NP 118-126 specific ex vivo CTL activities. Spleen cells werein the percentage of total CD8 T cells and a shift of CD8
incubated directly with Balb/c clone 7 (H-2d) cells coated with theT cells from the resting (LFA-1low) toward the activated
synthetic NP 118-126 peptide. Lysis of uncoated targets was below
(LFA-1high) phenotype (Figure 4A), a response that is rou- 5% for all effector populations (data not shown).
tinely seen in naive animals after LCMV clone 13 infec- (D) LCMV titers in the serum of rLM-immunized mice at different
tion (Matloubian et al., 1994). In contrast, mice immu- days after LCMV challenge. The dotted line indicates the limit of
detection.nized with XFL304, expressing the nonsecreted LCMV
epitope, had a much greater increase in the overall per-
centage of CD8 T cells, and the increase was even more
dramatic in the percentage of CD8 T cells with the acti- To assess the NP 118-126 specific CD8 T cell re-
vated (LFA-1high) phenotype. Similar results were ob- sponse, we measured the number of epitope-specific
served in mice vaccinated with the isogenic strain CD8 T cells and their direct ex vivo CTL activities at day
XFL303 and the positive control HSL236, both of which 8 after LCMV challenge of rLM immunized mice (Figures
4B and 4C). In mice immunized with XFL304 expressingsecrete the LCMV epitope.
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the nonsecreted epitope, the frequency of IFNg secret- nonsecreted bacterial proteins may also serve as pro-
tective antigens for CD8 T cell±mediated immunity. Toing lymphocytes specific for NP 118-126 was high (.106/
spleen), 100-fold more than in the negative control test this possibility, we asked if NP 118-126 specific CD8
T cells in LCMV immune mice can provide protectionHSL235 immunized mice and comparable to the levels
found in mice immunized with the epitope-secreting against rLM expressing a secreted or nonsecreted form
of the NP 118-126 epitope.strains XFL303 and HSL236. This frequency represents
more than 100-fold expansion of the NP 118-126 specific Balb/c mice were immunized with LCMV Armstrong,
which causes an acute infection that is resolved withinmemory CD8 T cells present before LCMV challenge
(about 104/spleen; Figure 3B). There was minimal lysis a week, resulting in the generation of LCMV-specific
memory CTL, the majority (.95%) of which are specificof NP 118-126 coated targets by splenocytes from the
animals immunized with the epitope-negative control to the NP 118-126 epitope (Whitton et al., 1989; van der
Most et al., 1996). At least 5 weeks after infection, thestrain HSL235. In contrast, mice immunized with XFL304,
expressing the nonsecreted NP 118-126 epitope, had LCMV immune mice and age-matched controls were
challenged with a lethal dose (z10 LD50) of the rLMhigh levels of NP 118-126 specific cytotoxicity, compa-
rable to mice immunized with the isogenic XFL303 and strains, and the number of bacteria in spleen and liver
were determinedat day 3 afterchallenge. LCMV immunepositive control HSL236 strains. Thus, mice immunized
with XFL304 expressing the nonsecreted epitope exhib- mice resisted infection with rLM strain HSL236 secreting
NP 118-126 as evidenced by a more than 10,000-foldited an enhanced NP 118-126 specific recall response
and total CD8 T cell expansion/activation that was com- reduction in the number of bacteria recovered in the
spleen and livers of LCMV immune mice compared toparable tomice immunized with XFL303or HSL236, both
of which secrete the epitope. naive mice (Figure 5A). This immunity against rLM is
specific for the NP 118-126 epitope because LCMV im-To determine whether CD8 T cells elicited in response
to a nonsecreted bacterial antigen can provide immunity mune mice fail to resist infection with strain HSL235,
which differs from HSL236 only by the absence of theto viral infection, virus titers in serum were measured
after LCMV clone 13 challenge of rLM immunized mice. NP 118-126 epitope.
LCMV immune mice also resisted infection by rLMAs shown in Figure 4D, mice immunized with the epi-
tope-negative control HSL235 strain had high virus titers strain XFL303, which secretes the LCMV NP 118-126
containing DHFR fusion protein, to a level similar to thatthroughout the experiment. In contrast, mice immunized
with XFL304, expressing the nonsecreted NP 118-126 seen with the positive control strain HSL236 (Figure 5A).
Thus, memory CD8 T cells specific for a single epitopeepitope, controlled viral replication to a similar degree
seen in mice immunized with the isogenic strain XFL303 mediate potent immunity against both rLM strains that
secrete the epitope containing fusion protein. Strikingly,and the positive control HSL236. The slightly delayed
kinetics of viral clearance in XFL304 immunized mice, the LCMV immune mice showed little, if any, specific
resistance to rLM strain XFL304 expressing the nonse-compared to mice vaccinated with HSL236 or XFL303,
is consistent with the 3-fold lower frequency of NP 118- creted NP 118-126 epitope. When survival was used
as readout, all LCMV immune mice infected with 105.2126 specific memory CD8 T cells induced by XFL304
compared to HSL236 or XFL303 immunization (Figures XFL304 died between 4±5 days postinfection. In con-
trast, 100% of LCMV immune mice survived a dose of2 and 3). Nevertheless, mice immunized with XFL304
cleared infectious virus by day 30 from serum, whereas 106.0 XFL303. These results demonstrate that CD8 T cells
specific to nonsecreted antigens are unable to controlin the epitope-negative HSL235-immunized mice, LCMV
clone 13 established a chronic infection with persistence bacterial infection.
Although XFL303 and XFL304 are isogenic strains, itof high virus titers.
In summary, four lines of evidence demonstrate effi- is still possible that differences could exist in the ability
of these two strains to colonize the host and/or counter-cient induction of CD8 T cells by a nonsecreted bacte-
rial antigen: priming of NP 118-126 specific CD8 T cells act the immune response. This notion is unlikely be-
cause the kinetics of a sublethal infection were compa-after immunization with a rLM expressing a nonsecreted
form of NP 118-126 epitope (XFL304); establishment of rable (data not shown), and similar numbers of bacteria
NP 118-126 specific memory after immunization with were recovered from the naive control animals after in-
XFL304; enhanced recall response after LCMV chal- fection with a lethal dose of XFL303 and XFL304 (Figure
lenge of XFL304-immunized mice; and protective im- 5A). We furtheraddressed this possibility by determining
munity against LCMV induced by XFL304 vaccination. the ability of XFL303 and XFL304 to grow in mice that
These results also demonstrate that CD8 T cells induced received LM immune splenocytes. In mice challenged
by a nonsecreted bacterial antigen are qualitatively no with either rLM strain, the transferred LM immune
different from CD8 T cells induced by its secreted coun- splenocytes reduced bacterial loads in spleens by more
terpart in that they are all capable of proliferating upon than 4000-fold and in livers by more than 2000-fold com-
LCMV challenge and deploying effector functions (i.e., pared to control mice that received PBS (Figure 5B).
lysis of infected targets and secretion of IFNg) that con- There was no significant difference between XFL303
trol viral infection. and XFL304 in the extent to which their growth was
limited by LM immune splenocytes. These data demon-
strate that the failure of NP 118-126 specific memoryMemory CD8 T Cells Specific for the Nonsecreted
Antigen Fail to Control Bacterial Infection CTL to control infection with XFL304 is not a conse-
quence of altered virulence or increased ability of thisThe ability of the nonsecreted epitope to prime CD8
T cell responses efficiently raises the possibility that rLM strain to evade immune defenses.
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Figure 6. Differential Recognition by CTL of Target Cells Infected
with rLM Expressing the Secreted or Nonsecreted Epitope
51Cr labeled±J774 (H-2d) cells were infected with the rLM strains
XFL303 (open square), XFL304 (filled square), HSL235 (open circle),
or uninfected (filled circle). Target cells were incubated for 4 hr with
CD8 T cells specific to LCMV NP 118-126 (A), LM p60 217-225 (B),
and LM LLO 91-99 (C). Data are from one representative experiment
of five with similar results.
vivo and the ability of CD8 T cells, specific for the same
antigen, to mediate protective immunity against bacte-
rial infection. As a first step toward understanding the
underling mechanism(s), we tested the hypothesis that
nonsecreted bacterial antigens may not be presented
in a manner that leads to CTL recognition and killing of
LM-infected cells.
Figure 5. The Nonsecreted Epitope Does Not Serve as a Target A CD8 T cell line specific to LCMV NP 118-126 was
Antigen for CD8 T Cell±Mediated Protective Immunity used to assess CD8 T cell recognition of secreted versus
(A) Balb/c mice were immunized with LCMV Armstrong to elicit nonsecreted bacterial antigens in a 51chromium (Cr) re-
NP 118-126 specific memory CD8 T cells. At least 1 month after lease assay (Figure 6A). J774 cells infected with rLM
immunization, LCMV immune mice (Immune) and naive controls strain XFL303, which secretes LCMV NP epitope, were
(Naive) were challenged with z10 LD50 of the rLM strains. Three efficiently lysed by NP 118-126 specific CD8 T cells. Indays after challenge, LM CFU in the spleen and liver were deter-
contrast, the same CD8 T cells mediated little specificmined. Data are from one representative experiment with six mice
lysis of J774 cells infected with rLM strain XFL304, whichin each group. Similar results were also obtained in two more inde-
pendent experiments. expresses the nonsecreted form of the epitope. Lysis
(B) LM immune splenocytes protect equally against rLM strains of XFL303-infected J774 at an effector to target ratio of
XFL303 and XFL304. Splenocytes from 10403S immunized mice 1:1 (20%) was higher than lysis of XFL304-infected cells
were transferred into naive mice. Recipients of LM immune spleno-
at an effector to target ratio of 30:1 (12%), demonstratingcytes (Immune) and PBS-injected controls (PBS) were challenged
greater than 30-fold increased lysis of target cells in-with 10 LD50 of XFL303 and XFL304. LM CFU in the spleen and liver
fected with rLM that secrete theepitope. Lack of specificwere determined 3 days postinfection. Data are pooled from two
independent experiments with a total of six mice in each group. lysis of XFL304-infected J774 cells by NP 118-126 spe-
cific CTL was not due to a lower level of infection be-
cause these cells were efficiently lysed by CD8 T cellsIn summary, we have used the NP 118-126 containing
specific to two native LM epitopes, p60 217-225 andDHFR fusion as a model bacterial antigen and demon-
LLO 91-99 (Figures 6B and 6C), which are secreted bystrated that epitope-specific CD8 T cells are able to
XFL304. Thus, J774 cells infected with rLM areefficientlycontrol listeriosis caused by bacteria that secrete the
lysed by CD8 T cells recognizing the secreted proteinsepitope but are unable to confer protection against bac-
but not by CD8 T cells directed against the nonsecretedteria that express the same epitope in a nonsecreted
model antigen.form. Therefore, compartmentalization of bacterial anti-
gens has a dramatic impact on the ability of memory
CD8 T cells to mediate protective immunity against LM Discussion
infection.
rLM as a Probe to Investigate Specific Interactions
between Intracellular BacteriaLM-Infected Cells Are Not Recognized by CD8
T Cells Specific to the Nonsecreted and the Immune System
The outcome of an infection is the result of a series ofBacterial Antigen
The failure of LCMV-specific memory CD8 T cells to complex interactions between the infectious agent and
the immune system. Analysis of these interactions re-provide in vivo immunity against XFL304 infection is in
direct contrast to the ability of this rLM strain to prime quires an in vivo experimental system in which a single
variable can be isolated without disturbing the naturalLCMV epitope-specific CD8 T cells effectively. These
results provide evidence of a discordance between the interactions between host and pathogen. We have pre-
viously described an experimental system that utilizesability of a bacterial antigen to activate CD8 T cells in
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rLM-expressing LCMV antigens to study CD8 T cell re- Presentation of bacterial antigens by an exogenous
sponses and protective immunity (Shen et al., 1995; pathway to CD8 T cells has been implicated in in vitro
Slifka et al., 1996; Jensen et al., 1997). This system studies using recombinant Escherichia coli and Salmo-
allows us to manipulate specific aspects of the bacte- nella typhimurium, organisms, which reside within the
rium and then analyze the impact of these changes on phagosome (Pfeifer et al., 1993; Wick et al., 1995). In
the immune response and the course of infection. contrast, LM gain access to both the phagosome and
In this study, we have examined the impact of bacterial cytoplasm of infected cells, and our study of antigen
antigen compartmentalization on in vivo priming of CD8 compartmentalization provides an experimental setting
T cells and protective immunity. Quantitative analysis in which the same antigen is accessible only by the
requires a direct comparison of the same antigen that exogenous pathway in one case (nonsecreted) and
is expressed in different bacterial compartments. In this readily available for the endogenous pathway in the
approach, selection of a suitable protein antigen be- other (secreted). This allows a direct comparison of the
comes a critical issue because naturally secreted pro- efficiency of the two pathways. Our data show that prim-
teins tend to be unstable when localized within the bac- ing of CD8 T cells in response to the nonsecreted bacte-
terial cytoplasm, whereas polypeptides that are not rial antigen is remarkably efficient to a level approaching
exported naturally are often inefficient in traversing the that of the endogenous pathway for priming of CD8 T
bacterial cell membrane (Simonen and Palva, 1993). We cells against the secreted LM antigen. Recently, several
tested several polypeptides, both naturally secreted and groups have argued that the exogenous pathway may
nonsecreted, and found that DHFR, a small cytoplasmic play a major role in the initiation of CD8 T cell responses
protein, can be efficiently exported by LM and is stable by allowing uninfected phagocytic cells to pick up exog-
when retained within bacterial cells. Using DHFR as a enous antigens and present them to CD8 T cells (Har-
carrier protein for a model CD8 T cell epitope, we con- ding, 1996; Jondal et al., 1996; Rock, 1996). Phagocytes,
structed a pair of isogenic rLM strains that express the such as macrophages and dendritic cells, are profes-
LCMV NP 118-126 epitope as part of a secreted or non- sional APC that are potent activators of naive T cells
secreted DHFR fusion protein. These isogenic strains as they express high levels of MHC class I, adhesion
are identical in every aspect except the localization of receptors, and costimulatory molecules. Although it has
the DHFR fusions, thus allowing us to assess precisely
been shown that exogenous antigens can elicit a CD8
the influence of bacterial antigen compartmentalization
T cell response by cross-priming, this study provides
on the CD8 T cell response in vivo.
experimental evidence demonstrating how remarkably
Our results show that both the secreted and nonse-
efficient this pathway can be in vivo.
creted forms of the NP 118-126 epitope can efficiently
Analysis of CD8 T cell responses to the recombinant
prime CD8 T cells. However, NP 118-126 specific mem-
and native LM epitopes revealed several additionalory CD8 T cells confer protection only against the rLM
points of interest. First, expression of the immunodomi-expressing the secreted epitope but not against the
nant LCMV NP 118-126 epitope by LM had no markedrLM expressing the nonsecreted epitope. These data
effect on CD8 T cell responses to the native LLO or p60underscore the importance of two distinct issues with
bacterial epitopes (Figures2 and 3). Second, the NP 118-regard to host immune responses: the question of gen-
126 response resulting from immunization with varyingerating a specific response, and the question of whether
doses of rLM was very similar to that of the native LMthe response is protective. Whereas previous work has
epitopes, with 300 bacteria being the threshold to inducefocused on one or the other independently, our ap-
a detectable response (Figure 2). Although a previousproach allows us to address both questions with the
study has documented protective immunity against LMsame antigenic system. Our studies reveal a striking
after immunization with 100 bacteria (Barry et al., 1992),dichotomy between priming of CD8 T cells and protec-
our results show that at this dose it is not possible totive immunity as a result of antigen compartmental-
detect CD8 T cell responses to individual epitopes. Thisization.
is not surprising because protective immunity against
LM is mediated by theconcerted action of multiple com-In Vivo Priming of CD8 T Cells by Secreted
ponents of the immune system. These include the entireand Nonsecreted Bacterial Antigens
repertoire of LM-specific CD8 and CD4 T cells, whichProteins secreted by intracellular LM into the host cell
may not individually reach the level detectable by ourcytosol are efficiently processed and presented to CD8
assays after low-dose immunization. Nevertheless, it isT cells by the endogenous MHC class I pathway (Vil-
important to note that at a dose of 300 bacteria, thelanueva et al., 1995). Nonsecreted bacterial proteins,
same mice that responded to the model NP 118-126on the other hand, are sequestered by the bacterial
epitope also mounted detectable responses to the na-cytoplasmic membrane and cell wall. However, it is
tive LM epitopes. Thus, the response to our model anti-known that a substantial fraction of LM are destroyed
gen is not aberrant but behaves identically to the re-by inflammatory neutrophils and macrophages shortly
sponse against the native LM antigens. Finally, theafter experimental infection (North, 1970; Rogers and
frequencies of NP 118-126 specific CD8 T cells afterUnanue, 1993). This destruction occurs in the phagoly-
rLM immunization were at least 10-fold lower than thatsosome prior to LM escape into the cytosol (de Chas-
induced by LCMV infection (Figure 3B) and were withintellier and Berche, 1994). Thus, bacterial lysis in the
the range seen with the two native LM epitopes (Figuresphagolysosome provides a mechanism by which nonse-
2 and 3). Therefore, the immunodominance of NP 118-creted bacterial proteins can become available for pro-
126 that is seen during LCMV infection is not an intrinsiccessing and presentation by an exogenous MHC class
I pathway. property of the peptide but is influenced by the nature
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late to prevent the progression of LM infection, which
includes direct cell-to-cell spread.
The above model, however, may not account for all
of our observations. The nonsecreted epitope is clearly
presented at a level sufficient for priming of naive CD8
T cells. The response to the nonsecreted epitope was
only 3- to 5-fold lower than that of the secreted NP 118-
126 and was higher than the response to a secreted LM
epitope p60 215-227 (Figures 2 and 3), which elicits CD8
T cells that provide immunity to LM infection (Harty and
Pamer, 1995). In addition, a rLM strain secreting a low
level of the NP 118-126 fusion induced a response that
was similar to that induced by the nonsecreted epitope,
yet this strain was controlled by NP 118-126 specific
memory CD8 T cells (Shen et al, unpublished data). Thus,
Figure 7. A Dichotomy between Priming of CD8 T Cells and Protec- quantitative differences in the efficiency of antigen pre-
tive Immunity as a Result of Antigen Compartmentalization sentation may not be the sole mechanism accounting
(A) A summary of the results. Secreted bacterial antigens stimulate for the striking difference between the secreted and
a CD8 T cell response, which in turn controls bacterial infection.
nonsecreted epitope in mediating antilisterial immunity.Nonsecreted proteins also stimulate a CD8 T cell response. How-
An alternative explanation comes from the observa-ever, these nonsecreted proteins do not serve as target antigens
tions that presentation of nonsecreted antigens by thefor CD8 T cell±mediated protective immunity.
(B) A proposed model. LM infects a variety of cells, including both exogenous MHC class I pathway may be limited to
phagocytic and nonphagocytic cells. In phagocytic cells, there is a phagocytes (Harding, 1996; Jondal et al., 1996; Rock,
competition between phagolysosomal fusion and LM escape into 1996), whereas LM infects both phagocytic and non-
the cytoplasm. LM that fail to escape are lysed, and nonsecreted
phagocytic cells (Cossart and Mengaud, 1989; Kauf-proteins become available for processing and presentation by the
mann, 1993). In this model (Figure 7B), nonsecreted bac-exogenous pathway to stimulate a CD8 T cell response, which may
terial proteins are presented only in a subset of infectedcontrol LM replication within this population of cells. However, these
CD8 T cells are unable to control LM infection because the nonse- cells, such as activated macrophages and/or other pro-
creted antigens are not presented on the surface of all infected fessional APC, which are capable of lysing LM and car-
cells, such as somatic cells, which are not known to kill intracellular rying out the exogenous pathway to stimulate a CD8 T
bacteria or to carry out the exogenous pathway of antigen presenta-
cell response. However, these CD8 T cells are unabletion. On the other hand, secreted proteins are presented by the
to control LM infection because the nonsecreted anti-endogenous pathway in all cell types, resulting in the generation of
gens are not presented on the surface of all infectedCD8 T cell responses that can in turn recognize all infected cells
and control listeriosis. In addition to this model, quantitative differ- cells. In contrast, secreted proteins are accessible for
ences in antigen presentation may also contribute the observed presentation by the endogenous pathway in all cell
dichotomy (see Discussion). types, resulting in CD8 T cell recognition of all infected
cells and control of listeriosis.
It should be pointed out that the two models are not
of the infectious organism that expresses the epitope. mutually exclusive and both scenarios may occur simul-
Together, these observations indicate that the similar taneously in vivo. In principle, both models invoke that
priming of CD8 T cells by the secreted and nonsecreted secreted and nonsecreted bacterial proteins are pre-
epitope was not due to saturation of the endogenous sented by the endogenous and exogenous pathways,
pathway during rLM infection or due to any unusual respectively, to stimulate a CD8 T cells response. How-
properties of the model epitope. ever, CTL recognition leading to protective immunity
may require antigen presentation by the widely distrib-
The Dichotomy between Priming of CD8 T Cells uted endogenous pathway. It is also important to point
and Protective Immunity as a Result out that these models illustrate a defined aspect of a
of Antigen Compartmentalization complex immune response. During LM infection, many
Whereas both the secreted and nonsecreted epitope components of the immune system are activated and
can efficiently prime a CD8 T cell response, NP 118-126 multiple antigens are recognized by both CD4 and CD8
specific CD8 T cells control infection by rLM secreting T cells. Our ability to specifically manipulate the antigen
the epitope but not by rLM expressing the nonsecreted and analyze CD8 T cell responses to a single epitope
epitope. These results highlight a divergence between allowed us to achieve a level of resolution that is other-
priming of CD8 T lymphocytes and CD8 T cell±mediated wise not possible.
protective immunity (Figure 7A). What is the mecha-
nism(s) accounting for this dichotomy? An obvious ex-
planation is that nonsecreted antigens are presented Implications for Vaccine Development
Vaccination against pathogenic microbes requires effi-less efficiently than secreted ones, leading to fewer sur-
face MHC-peptide complexes, delayed surface display cient delivery of antigens that elicit protective immune
responses. In recent years several bacteria includingof these complexes, or a combination of the two. These
could translate into suboptimal activation of memory LM have been exploited as an antigen delivery vehicle
for the induction of cell-mediated immunity (IkonomidisCD8 T cells or delayed recognition of target cells such
that the CD8 T cell responses are either too weak or too et al., 1994; Frankel et al., 1995; Pan et al., 1995; Shen
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the numbers of LM CFU were determined in organ homogenates ofet al., 1995; Hess et al., 1996; Slifka et al., 1996). Such
spleens and livers as described (Harty and Bevan, 1995).effort has, in some cases, been hampered by the inability
LCMV stocks were triple plaque purified on Vero cells and grownof bacteria to export some of the foreign antigens effi-
in BHK-21 cells as described (Ahmed et al., 1984). To make LCMV
ciently. Our results indicate that antigen secretion is not immune mice, 6-week-old female Balb/c mice were infected intra-
as critical as previously perceived for the induction of peritoneally with 2 3 105 plaque forming units (PFU) of the Armstrong
CA 1371 strain. A virulent strain of LCMV, clone 13, was used toCD8 T cells by rLM. On the other hand, our data show
challenge rLM immunized mice. At least 2 months after rLM immuni-that nonsecreted proteins may not be suitable targets
zation, mice were infected intravenously with 2 3 106 PFU clone 13.for CD8 T cell±mediated protective immunity. The rules
Infectious virus in serum and tissues was quantitated as describeddetermining which bacterial antigens elicit immune re-
(Ahmed et al., 1984).
sponses and which responses result in protective immu- For adoptive transfer experiment, 5 3 107 splenocytes from LM-
nity are largely unknown. This study uncovers antigen immune Balb/c mice were transferred by intravenous injection into
naive Balb/c mice. One hour later, these mice and PBS-injectedcompartmentalization as one mechanistic reason for
controls were challenged with 10 LD50 of rLM strains by intravenouswhy the response to a particular antigen may not be
injection. CFU per spleen and liver were determined 3 days post±rLMprotective. This is likely to be a general feature of CD8
infection.T cell±mediated immunity against infections by intracel-
lular bacteria, fungi, and protozoa. For these complex
Limiting Dilution, IFNg Elispot, and CTL Assayspathogens, which express thousands of distinct poly-
Limiting dilution assays for quantitation of NP 118-126 specificCTLp
peptides, focus on the relatively small fraction of se- were carried out as previously described (Lau et al., 1994). IFNg-
creted antigens would enhance efforts to identify effec- secreting lymphocytes were measured by Elispot assays (Murali-
tive vaccine antigens for eliciting protective CD8 T cell Krishna et al., 1998). Synthetic peptides (NP 118-126, LLO 91-99,
and p60 217-225) were used to stimulate splenocytes overnight atresponses.
a final concentration of 0.1 mg/ml, and parallel no peptide controlsMuch has been learned about the molecular bases of
were included. Background from unstimulated controls was minimalbacterial pathogenesis and cellular immune surveillance
(,1/105 spleen cells) and was subtracted.
in recent years. As illustrated in this report, combining Direct ex vivo CTL activity was measured using a standard 6 hr
the experimental advances in these two fields is a pow- 51Cr release assay (Ahmed et al., 1984). Target cells are Balb/c clone
erful approach, which will provide answers to many ba- 7 (H-2d) cells coated with the synthetic NP 118-126 peptide (final
0.1 mg/ml) and uncoated controls. CTL assays of rLM-infected J774sic questions concerning host±pathogen interactions
(H-2d) cells were performed using NP 118-126, LLO 91-99, p60 217-and guidelines for the rational design of vaccines.
225±specific CD8 T cell lines as previously described (Harty and
Bevan, 1995; Harty and Pamer, 1995).
Experimental Procedures
Flow CytometryConstruction of rLM Strains
Fluorescein isothiocyanate-conjugated rat anti-mouse LFA-1 andDNA sequences encoding DHFR, the hly promoter, and signal se-
phycoerythrin-conjugated rat anti-mouse CD8a were purchasedquence were amplified by PCR from pEH18 (Hurt et al., 1984) and
from Pharmingen (San Diego, CA) and used for staining of spleno-LM chromosomal DNA, respectively. Two complementary oligonu-
cytes in PBS containing 1% bovine serum albumin and 0.2% sodiumcleotides were synthesized for sequences encoding the NP 118-
azide for 30 min at 48C. Analyses were performed on a FACScan126 epitope (van der Most et al., 1996) and the monoclonal antibody
flow cytometer (Becton Dickinson, San Francisco, CA).epitopes, Ha from influenza virus hemoglutinin (Kolodziej and
Young, 1991) and Vg from vesicular stomatitis virus glycoprotein
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